Commercial and IP Strategy

“I have had the pleasure of working with Dr. Michael Murray and he has a unique set of skills and expertise. He has an ability to find the value in an Intellectual Property (IP) asset and develop a creative commercialisation strategy for extracting the maximum value from that IP. Dr. Murray is a professional IP specialist able to establish credibility and build valuable relationships on behalf of his clients. I have no hesitation in recommending Dr. Murray and the services his company offers.”

Vice President at a multinational open innovation company, THE NETHERLANDS

“Dr Murray provided our company with timely, focused and insightful advice on a complicated portfolio product.  I commend his services to you.”

CEO & Managing Director of a biotechnology drug development company, AUSTRALIA

“Our patent estate is our single most important asset and the effective oversight and management of this asset is a high priority for us. We engaged Michael Murray to help us develop a robust and coherent strategy over a 2-year period for our current and planned patent estate. Michael brought unique insights and perspectives that have been central to helping us achieve these aims and that are a perfect complement to the operational advice that we receive from our patent agents.”

CEO of a drug development company, UNITED KINGDOM

“Dr Michael Murray gave us valuable insight into how to structure our know-how and intellectual property into categories that both protected our IP and maximised its commercial impact. Not only did Michael provide invaluable assistance it was an absolute pleasure working with him.”

CEO of a nano-biotechnology company, UNITED KINGDOM

IP Valuation

“When our company emerged from an intellectual property fight having won the arguments, we had a need to assess the value of the enlarged patent portfolio to provide comfort to our investors and the financial community.  IP battles can decimate the perceived value of an SME, and in order to get the company back on track an independent valuation of the company's asset was needed.  Dr Murray's expertise in this area is unparalleled.  He has defined the space of valuing IP assets for the small and emerging company.  His IP background and his understanding of the growth trajectory of companies based on solid patenting was a huge positive in our ability to raise new funding and establish a solid valuation for our company. I highly recommend IP based firms consider getting an independent view of what they have.  Dr Murray and his team will not disappoint.”

CEO of a hospital product company, REPUBLIC OF IRELAND

 Licensing and Acquisition

“We approached Mike regarding a patent that we had stumbled into which we would likely be infringing without negotiating some form of licence with the US based University that owned it. Mike tracked down the IP group at the University and engaged in a complex and protracted negotiation. The end result was a complete purchase of the patent at a competitive rate for what is a key ingredient in allowing us to realise a major project in our product roadmap. The addition result of now being able to block our competition from pursuing this project surpassed our initial expectation.”

CEO of a medical equipment company, UNITED KINGDOM

“Michael was called in to help with a complex negotiation of a multi-year, multiple project deal with one of the largest pharmaceutical companies in the world. His experience and out-of-the-box thinking were invaluable to what was essentially a “David and Goliath” situation. We were successful because Michael was cognisant and sensitive to all aspects of the deal, from a deep understanding of the science, to the financial mechanics, to the politics of the various stakeholders involved.”

Managing Director of a technology platform and product development company, UNITED KINGDOM

“Michael brings a lifetime’s experience in understanding, shaping and negotiating deals. For companies like us, that have focused on R&D and manufacturing, those skills are invaluable.”

CEO of a metabolic disease treatment company, UNITED KINGDOM